Carbamazepine: Placental Transport, Tissue Concentrations in Foetus and Newborn, and Level in Milk
Authors:
- 1 September 1977
- journal article
- research article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 41 (3) , 244-253
Abstract
The pharmacokinetics of carbamazepine were studied during pregnancy and early childhood by investigating the extent of its placental penetration and its distribution in the foetal and neonatal tissues at autopsy. In foetuses the liver and kidney contained high levels of carbamazepine, whereas brain and lungs had low values. Carbamazepine‐10,11‐epoxide was also detected in the foetal circulation. At autopsy material, carbamazepine was localized mostly in the cerebral cortex, heart, liver and kidney. The concentration of carbamazepine in the milk was found to be 60 per cent of the respective plasma value.Keywords
This publication has 19 references indexed in Scilit:
- Placental transfer of carbamazepine in the ratJournal of Pharmacy and Pharmacology, 1975
- Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicityInternational Journal of Cancer, 1975
- Drug metabolism in the human neonateLife Sciences, 1975
- Pharmacokinetic Data of Carbamazepine and Its Major Metabolites in Man1975
- Plasma disappearance of transplacentally transferred diphenylhydantoin in the newborn studied by mass fragmentographyClinical Pharmacology & Therapeutics, 1974
- Drug metabolism by placentaClinical Pharmacology & Therapeutics, 1973
- PHENYTOIN TERATOGENICITY IN MANThe Lancet, 1973
- Carbamazepine plasma and tissue levels in the ratBiochemical Pharmacology, 1971
- Diphenylhydantoin: Placental transport, fetallocalization, neonatal metabolism, and possible teratogenic effectsThe Journal of Pediatrics, 1971
- The effect of growth and function on the chemical composition of soft tissuesBiochemical Journal, 1960